BACKGROUND AND OBJECTIVES
Clinical management of mineral bone disorder in patients with kidney failure is guided by biochemical targets, in particular parathyroid hormone (PTH) concentration. The biologic variation of PTH and other bone mineral markers was measured in hemodialysis patients to better define their role in management.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS
Intact PTH, bio...